Jeff, You are correct. Only slightly netter tha
Post# of 148172
You are correct. Only slightly netter that the EIND here, as chiral will be doing the legwork.
As well, only Crumbs of revenue over the short term for Cytodyn.
Small but important first step, for Cytodyn and patients in the Philippines.
The biggest value, IMO, is that the commitment of doses maintains pressure on FDA not to dawdle.